The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.
ApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype
Open accessAbstract
Abstract —The study assessed the efficacy of fish oil supplementation in counteracting the classic dyslipidemia of the atherogenic lipoprotein phenotype (ALP). In addition, the impact of the common apolipoprotein E (apoE) polymorphism on the fasting and postprandial lipid profile and on responsiveness to the dietary intervention was established. Fifty-five ALP males (aged 34 to 69 years, body mass index 22 to 35 kg/m 2 , triglyceride [TG] levels 1.5 to 4.0 mmol/L, high density lipoprotein cholesterol [HDL-C] <1.1 mmol/l, and percent low density lipoprotein [LDL]-3 >40% total LDL) completed a randomized placebo-controlled crossover trial of fish oil (3.0 g eicosapentaenoic acid/docosahexaenoic acid per day) and placebo (olive oil) capsules with the 6-week treatment arms separated by a 12-week washout period. In addition to fasting blood samples, at the end of each intervention arm, a postprandial assessment of lipid metabolism was carried out. Fish oil supplementation resulted in a reduction in fasting TG level of 35% ( P <0.001), in postprandial TG response of 26% (TG area under the curve, P <0.001), and in percent LDL-3 of 26% ( P <0.05). However, no change in HDL-C levels was evident ( P =0.752). ANCOVA showed that baseline HDL-C levels were significantly lower in apoE4 carriers ( P =0.035). The apoE genotype also had a striking impact on lipid responses to fish oil intervention. Individuals with an apoE2 allele displayed a marked reduction in postprandial incremental TG response (TG incremental area under the curve, P =0.023) and a trend toward an increase in lipoprotein lipase activity relative to non-E2 carriers. In apoE4 individuals, a significant increase in total cholesterol and a trend toward a reduction in HDL-C relative to the common homozygous E3/E3 profile was evident. Our data demonstrate the efficacy of fish oil fatty acids in counteracting the proatherogenic lipid profile of the ALP but also that the apoE genotype influences responsiveness to this dietary treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although most trials presented in Table 4 specified direct LDL-C measurement in cases when triglycerides >400 mg/dL (as is standard for clinical practice), only 3 trials reported LDL-C results obtained from direct LDL measurement throughout the triglyceride range.28,30,45”
From Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019) · cites this paper as [45]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On average, the triglyceride reduction was ≈27% (range, 21%-35%), apart from the study of a medical food (3.2 g/d EPA+DHA), which specifically recruited people with very low blood levels of n-3 FA and reported a 48% reduction.”
From Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019) · cites this paper as [45]
Experimental — accuracy not yet measuredIn the citing paper
“Total cholesterol levels increased in APOE4 carriers and, although not statistically significant, LDL-C levels tended to increase more in APOE4 carriers than in APOE2 or APOE3 carriers following OM3FA treatment.”
In the citing paper
“However, small dense LDL levels decreased similarly in the different APOE genotypes [59].”
In the citing paper
“Minihane et al. were the first to show that the effect of OM3FAs on LDL was dependent on APOE genotype [59].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review
Harris, W. S. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38310-3 · Cited by 1,127
Lipolytic Enzymes and Plasma Lipoprotein Metabolism
Nilsson‐Ehle, P., Garfinkel, A. S., & Schotz, M. C. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.003315 · Cited by 754
Research works printed but not linked: 18
- 10.1161/atv91.11.1.1987999 · DOI
- 1994, Atherosclerosis, 197, 106
- 10.1161/atv91.14.11.7947602 · DOI
- 10.1161/circ.82.2.2372896 · DOI
- 1988, JAMA, 260, 917
- 1980, Trans Assoc Am Physicians, 43, 148
- 1988, J Clin Invest, 82, 1844
- 1988, J Lipid Res, 299, 1451
- 1994, Am J Hum Genet, 54, 341
- 10.1161/atv91.11.6.1931875 · DOI
- 1995, Clin Chem, 4, 1599
- 1986, J Lipid Res, 27, 227
- 1986, J Clin Invest, 11, 1303
- 10.1161/atvb.17.9.1675 · DOI
- 1984, J Clin Invest, 74, 72
- 1994, Eur J Clin Nutr, 48, 26
- Minihane AM Khan S Talmud PJ Williams DL Wright JW Murphy MC Griffin BA Williams CM. In subjects with an atherogenic lipoprotein phenotype (ALP) central adiposity is associated with an attenuated postprandial triglyceride response. Int J Obes. In press.
- 10.1161/atv91.13.12.8241095 · DOI
Cited by
Sorted by citations
Skulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000709 · Cited by 512
Gene-Environment Interplay in Relation to Emotional and Behavioral Disturbance
Rutter, M. L., & Silberg, J. L. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135223 · Cited by 462
The health effects of dietary unsaturated fatty acids
Lunn, J., & Theobald, H. E. (2006) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2006.00571.x · Cited by 416
Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease
Marais, A. D. (2019) · Pathology · doi:10.1016/j.pathol.2018.11.002 · Cited by 382
Are all n-3 polyunsaturated fatty acids created equal?
Anderson, B. M., & David, W. L. (2009) · Lipids in Health and Disease · doi:10.1186/1476-511x-8-33 · Cited by 344
Fish, docosahexaenoic acid and Alzheimer’s disease
Cunnane, S. C., Plourde, M., Pifferi, F., Bégin, M. E., Féart, C., & Barberger‐Gateau, P. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.04.001 · Cited by 336
Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
Hartweg, J., Perera, R., Montori, V. M., Dinneen, S. F., Neil, A. H., & Farmer, A. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003205.pub2 · Cited by 282
Finnegan, Y. E., Minihane, A. M., Leigh-Firbank, E. C., Kew, S., Meijer, G. W., Müggli, R., Calder, P. C., & Williams, C. M. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.4.783 · Cited by 246
Self-citationRivellese, A. A., Maffettone, A., Vessby, B., Uusitupa, M., Hermansen, K., Berglund, L., Louheranta, A., Meyer, B. J., & Riccardi, G. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00424-0 · Cited by 198
Genetic variation and the lipid response to dietary intervention: a systematic review
Masson, L. F., McNeill, G., & Avenell, A. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1098 · Cited by 196
Egert, S., Boesch, C., Wolffram, S., Rimbach, G. H., & Müller, M. J. (2009) · Journal of Nutrition · doi:10.3945/jn.109.117655 · Cited by 194
Griffin, M., Sanders, T. A. B., Davies, I. G., Morgan, L., Millward, D. J., Lewis, F., Slaughter, S. L., Cooper, J. A., Miller, G. J., & Griffin, B. A. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.6.1290 · Cited by 190
Self-citationWhalley, L. J., Deary, I. J., Starr, J. M., Wahle, K. W. J., Rance, K. A., Bourne, V. J., & Fox, H. C. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.2.449 · Cited by 180
Griffin, B. A. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f2e2a8 · Cited by 168
Self-citationVarady, K. A., & Jones, P. J. H. (2005) · Journal of Nutrition · doi:10.1093/jn/135.8.1829 · Cited by 164
Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study
CASLAKE, M. J., Miles, E. A., Kofler, B. M., Lietz, G., Curtis, P., Armah, C. K., Kimber, A., Grew, J., Farrell, L., Stannard, J., et al. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.618 · Cited by 162
Self-citationOscarsson, J., & Hurt-Camejo, E. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0541-3 · Cited by 158
Methodology for studying postprandial lipid metabolism
Lairon, D., López‐Miranda, J., & Williams, C. M. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602749 · Cited by 159
Self-citationRole of n−3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease
Jacobson, T. A. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1981s · Cited by 147
Khan, S., Minihane, A.-M., Talmud, P. J., Wright, J. W., Murphy, M. C., Williams, C. M., & Griffin, B. A. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30473-9 · Cited by 145
Self-citationTargeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids
Astarita, G., Kendall, A. C., Dennis, E. A., & Nicolaou, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.012 · Cited by 140
APOE genotype and stress response - a mini review
Dose, J., Huebbe, P., Nebel, A., & Rimbach, G. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0288-2 · Cited by 137
ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation
Minihane, A. M., Jofre‐Monseny, L., Olano-Martin, E., & Rimbach, G. H. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005435 · Cited by 128
Self-citationAbuMweis, S., Jew, S., Tayyem, R., & Agraib, L. (2018) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12493 · Cited by 122
Wilkinson, P. M. H., Leach, C., Ah-Sing, E., Hussain, N., Miller, G. J., Millward, D. J., & Griffin, B. A. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.029 · Cited by 121
Self-citationBuckley, R., Shewring, B., Turner, R., Yaqoob, P., & Minihane, A. M. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041235 · Cited by 118
Self-citationThe future direction of personalised nutrition: my diet, my phenotype, my genes
Gibney, M. J., & Walsh, M. C. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112003436 · Cited by 112
Dietary supplementation with a natural carotenoid mixture decreases oxidative stress
Kiokias, S. N., & Gordon, M. H. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601655 · Cited by 112
Sanders, T. A. B., Gleason, K. L. T., Griffin, B. A., & Miller, G. J. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20051658 · Cited by 122
Self-citationAn Emerging Role for Metabolomics in Nutrition Science
Astarita, G., & Langridge, J. (2013) · Lifestyle Genomics · doi:10.1159/000354403 · Cited by 110
Leigh-Firbank, E. C., Minihane, A. M., Leake, D. S., Wright, J. W., Murphy, M. C., Griffin, B. A., & Williams, C. M. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002556 · Cited by 108
Self-citationLDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women.
Theobald, H. E., Chowienczyk, P. J., Whittall, R., Humphries, S. E., & Sanders, T. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.558 · Cited by 101
Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids
Nording, M. L., Yang, J., Georgi, K., Hegedus Karbowski, C., German, J. B., Weiss, R. H., Hogg, R. J., Trygg, J., Hammock, B. D., & Zivkovic, A. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076575 · Cited by 100
Omega-3 Fatty Acids in Boxer Dogs with Arrhythmogenic Right Ventricular Cardiomyopathy
Smith, C. E., Freeman, L. M., Rush, J. E., Cunningham, S. M., & Biourge, V. C. (2007) · Journal of Veterinary Internal Medicine · doi:10.1892/0891-6640(2007)21[265:ofaibd]2.0.co;2 · Cited by 110
ApoE genotype: from geographic distribution to function and responsiveness to dietary factors
Egert, S., Rimbach, G. H., & Huebbe, P. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000249 · Cited by 97
Are the health benefits of fish oils limited by products of oxidation?
Turner, R., McLean, C. H., & Silvers, K. M. (2006) · Nutrition Research Reviews · doi:10.1079/nrr2006117 · Cited by 94
Hepatotoxicity of hypolipidemic drugs
Parra, J. L., & Reddy, K. R. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00024-2 · Cited by 93
Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia
Skulas-Ray, A. C., West, S. G., Davidson, M. H., & Kris-Etherton, P. M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1237 · Cited by 91
Lovegrove, J. A., Lovegrove, S. S., Lesauvage, S. V., Brady, L. M., Saini, N., Minihane, A. M., & Williams, C. M. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.974 · Cited by 88
Self-citationPersonalised nutrition: ready for practice?
de Roos, B. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112002844 · Cited by 88
Le, H. D., de Meijer, V. E., Robinson, E. M., Zurakowski, D., Potemkin, A. K., Arsenault, D. A., Fallon, E. M., Malkan, A. D., Bistrian, B. R., Gura, K. M., et al. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.008557 · Cited by 85
Olano-Martin, E., Anil, E., Caslake, M. J., Packard, C. J., Bedford, D., Stewart, G., Peiris, D., Williams, C. M., & Minihane, A. M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.024 · Cited by 83
Self-citationCarvalho-Wells, A. L., Jackson, K. G., Lockyer, S., Lovegrove, J. A., & Minihane, A. M. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.043240 · Cited by 82
Self-citationAdvanced Lipoprotein Testing and Subfractionation Are Clinically Useful
Superko, H. R. (2009) · Circulation · doi:10.1161/circulationaha.108.809582 · Cited by 78
Genetic evaluation for coronary artery disease
Scheuner, M. T. (2003) · Genetics in Medicine · doi:10.1097/01.gim.0000079364.98247.26 · Cited by 74
Bhatnagar, D., & Durrington, P. N. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10490.x · Cited by 72
Hietaranta-Luoma, H.-L., Tahvonen, R., Iso‐Touru, T., Puolijoki, H., & Hopia, A. (2014) · Lifestyle Genomics · doi:10.1159/000371743 · Cited by 68
Madden, J., Williams, C. M., Calder, P. C., Lietz, G., Miles, E. A., Cordell, H. J., Mathers, J. C., & Minihane, A. M. (2011) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-010411-095239 · Cited by 68
Self-citationChouinard‐Watkins, R., & Plourde, M. (2014) · Nutrients · doi:10.3390/nu6104452 · Cited by 73
The impact of EPA and DHA on blood lipids and lipoprotein metabolism: influence of apoE genotype
Anil, E. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005307 · Cited by 69
Maki, K. C., Elswyk, M. E. V., McCarthy, D., Hess, S. P., Veith, P. E., Bell, M., Subbaiah, P. V., & Davidson, M. H. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719465 · Cited by 66
Steffen, B. T., Steffen, L. M., Tracy, R. P., Siscovick, D. S., Jacobs, D. R., Liu, K., He, K., Hanson, N. Q., Nettleton, J. A., & Tsai, M. Y. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.215 · Cited by 63
Impact of Genotype on EPA and DHA Status and Responsiveness to Increased Intakes
Minihane, A. M. (2016) · Nutrients · doi:10.3390/nu8030123 · Cited by 64
Self-citationThota, R. N., Ferguson, J. J. A., Abbott, K. A., Dias, C. B., & Garg, M. L. (2018) · Food & Function · doi:10.1039/c8fo00348c · Cited by 60
α-Linolenic acid but not conjugated linolenic acid is hypocholesterolaemic in hamsters
Yang, L., Leung, K. Y., Cao, Y., Huang, Y., Ratnayake, W. M. N., & Chen, Z. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20041365 · Cited by 62
Zerbi, V., Jansen, D., Wiesmann, M., Fang, X. T., Broersen, L. M., Veltien, A. A., Heerschap, A., & Kiliaan, A. J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.038 · Cited by 62
A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice
Wiesmann, M., Zerbi, V., Jansen, D., Haast, R., Lütjohann, D., Broersen, L. M., Heerschap, A., & Kiliaan, A. J. (2016) · Neural Plasticity · doi:10.1155/2016/6846721 · Cited by 60
Phelan, N., O’Connor, A., Kyaw Tun, T., Correia, N., Boran, G., Roche, H. M., & Gibney, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005538 · Cited by 89
Poppitt, S. D., Howe, C., Lithander, F. E., Silvers, K. M., Lin, R., Croft, J., Ratnasabapathy, Y., Gibson, R. A., & Anderson, C. S. (2009) · Stroke · doi:10.1161/strokeaha.109.555136 · Cited by 59
Fat and Fatty Acid Intake and Metabolic Effects in the Human Body
Sanders, T. A. B. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000229001 · Cited by 58
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
Ramalho, R., Rao, M., Zhang, C., Agrati, C., Ippolito, G., Wang, F., Zumla, A. I., & Maeurer, M. J. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00798-w · Cited by 63
Physiological Factors Influencing Vitamin E Biokinetics
Lodge, J. K., Hall, W. L., Jeanes, Y., & Proteggente, A. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1331.006 · Cited by 58
Chouinard‐Watkins, R., Conway, V., Minihane, A. M., Jackson, K. G., Lovegrove, J. A., & Plourde, M. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.103507 · Cited by 63
Self-citationTholstrup, T., Hellgren, L. I., Petersen, M., Basu, S., Straarup, E. M., Schnohr, P., & Sandström, B. (2004) · Journal of Nutrition · doi:10.1093/jn/134.5.1051 · Cited by 55
Mostad, I. L., Bjerve, K. S., Lydersen, S., & Grill, V. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602703 · Cited by 55
Thomas, T. R., SMITH, B. K., Donahue, O. M., Altena, T. S., James-Kracke, M., & Sun, G. Y. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.019 · Cited by 55
Danthiir, V., Burns, N. R., Nettelbeck, T., Wilson, C. J., & Wittert, G. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-117 · Cited by 55
Rudkowska, I., Guénard, F., Julien, P., Couture, P., Lemieux, S., Barbier, O., Calder, P. C., Minihane, A. M., & Vohl, M. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m045898 · Cited by 53
Self-citationDietary fat and postprandial lipids
Sanders, T. A. B. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0034-x · Cited by 53
Griffin, B. A., Walker, C. G., Jebb, S. A., Moore, C. S., Frost, G. S., Goff, L. M., Sanders, T. A. B., Lewis, F., Griffin, M., Gitau, R., et al. (2018) · Nutrients · doi:10.3390/nu10101524 · Cited by 54
Self-citationMetabotyping and its role in nutrition research
Hillesheim, E., & Brennan, L. (2019) · Nutrition Research Reviews · doi:10.1017/s0954422419000179 · Cited by 52
The challenges for molecular nutrition research 1: linking genotype to healthy nutrition
Williams, C. M., Ordovás, J. M., Lairon, D., Hesketh, J. E., Lietz, G., Gibney, M. J., & van Ommen, B. (2008) · Genes & Nutrition · doi:10.1007/s12263-008-0086-1 · Cited by 51
Self-citationOmega-3 fatty acids: Benefits for cardio-cerebro-vascular diseases
Siegel, G., & Ermilov, E. A. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.006 · Cited by 52
Inflammatory, Apoptotic, and Survival Gene Signaling in Alzheimer’s Disease
Lukiw, W. J., & Bazan, N. G. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8126-4 · Cited by 50
Fallaize, R., Carvalho-Wells, A. L., Tierney, A. C., Marín, C., Kieć‐Wilk, B., Dembinska-Kiec, A., Drevon, C. A., Defoort, C., López‐Miranda, J., Risérus, U., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05802-2 · Cited by 54
Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease
Goozee, K. G., Chatterjee, P., JAMES, I. R., Shen, K., Sohrabi, H. R., Asih, P. R., Dave, P., Ball, B., ManYan, C., Taddei, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00751-2 · Cited by 48
Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages
Jofre‐Monseny, L., de Pascual‐Teresa, S., Plonka, E., Huebbe, P., Boesch, C., Minihane, A. M., & Rimbach, G. H. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507669219 · Cited by 47
Self-citationPaschos, G. K., Yiannakouris, N., Rallidis, L. S., Davies, I. G., Griffin, B. A., Panagiotakos, D. B., Skopouli, F. N., Votteas, V., & Zampelas, A. (2005) · Angiology · doi:10.1177/000331970505600107 · Cited by 44
Self-citationImplications of apolipoprotein E genotype on inflammation and vitamin E status
Huebbe, P., Lodge, J. K., & Rimbach, G. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900398 · Cited by 43
Personalized nutrition for the prevention of cardiovascular disease: a future perspective
Lovegrove, J. A., & Gitau, R. (2008) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2008.00889.x · Cited by 46
Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there?
Rimbach, G. H., & Minihane, A. M. (2009) · Proceedings of The Nutrition Society · doi:10.1017/s0029665109001116 · Cited by 47
Self-citationFish oil and the management of hypertriglyceridemia
Mattar, M., & Obeid, O. (2009) · Nutrition and Health · doi:10.1177/026010600902000105 · Cited by 43
Le, H. D., de Meijer, V. E., Zurakowski, D., Meisel, J. A., Gura, K. M., & Puder, M. (2010) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607110371806 · Cited by 45
Thifault, É., Cormier, H., Bouchard‐Mercier, A., Rudkowska, I., Paradis, A.-M., Garneau, V., Ouellette, C., Lemieux, S., Couture, P., & Vohl, M. (2013) · Lifestyle Genomics · doi:10.1159/000350744 · Cited by 43
Impact of Oil used by the Frying Industry on Population Fat Intake
Minihane, A. M., & Harland, J. I. (2007) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390600737821 · Cited by 44
Self-citationThe effect of n−3 fatty acids on low density lipoprotein subfractions
Griffin, B. A. (2001) · Lipids · doi:10.1007/s11745-001-0688-6 · Cited by 42
Self-citationOmega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis
Guichardant, M., Calzada, C., Bernoud‐Hubac, N., Lagarde, M., & Véricel, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.013 · Cited by 42
Associations between apolipoprotein E genotype and circulating F2‐isoprostane levels in humans
Dietrich, M., Hu, Y., Block, G., Olano-Martin, E., Packer, L., Morrow, J. D., Hudes, M. L., Abdukeyum, G., Rimbach, G. H., & Minihane, A. M. (2005) · Lipids · doi:10.1007/s11745-006-1390-4 · Cited by 41
Self-citationEgert, S., Lindenmeier, M., Harnack, K., Krome, K., Erbersdobler, H. F., Wahrburg, U., & Somoza, V. (2012) · Journal of Nutrition · doi:10.3945/jn.112.161802 · Cited by 41
Oelrich, B., Dewell, A., & Gardner, C. D. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.06.003 · Cited by 41
Finkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 41
Pharmacogenomics and nutrigenomics: synergies and differences
GHOSH, D. K., Skinner, M. A., & Laing, W. A. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602590 · Cited by 39
Minihane, A. M., Brady, L. M., Lovegrove, S. S., Lesauvage, S. V., Williams, C. M., & Lovegrove, J. A. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-0488-9 · Cited by 39
Self-citationChristidis, D. S., Liberopoulos, E. N., Kakafika, A. I., Miltiadous, G. A., Cariolou, M. A., Ganotakis, E. S., Mikhailidis, D. P., & Elisaf, M. (2006) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248406293732 · Cited by 38
Genomic interactions with disease and nutrition
Paoloni‐Giacobino, A., Grimble, R. F., & Pichard, C. (2003) · Clinical Nutrition · doi:10.1016/s0261-5614(03)00091-8 · Cited by 38
Interactions between age and apoE genotype on fasting and postprandial triglycerides levels
Carvalho-Wells, A. L., Jackson, K. G., Gill, R. D., Olano-Martin, E., Lovegrove, J. A., Williams, C. M., & Minihane, A. M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.06.036 · Cited by 40
Self-citationLiang, S., Steffen, L. M., Steffen, B. T., Guan, W., Weir, N. L., Rich, S. S., Manichaikul, A. W., Vargas, J. D., & Tsai, M. Y. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.004 · Cited by 37
Fish oil in the treatment of dyslipidemia
Goldberg, R. B., & Sabharwal, A. K. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282f76728 · Cited by 37
Apolipoprotein E and diets: a case of gene-nutrient interaction?
Rubin, J., & Berglund, L. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00005 · Cited by 37
Exercise plus n-3 fatty acids: Additive effect on postprandial lipemia
SMITH, B. K., Sun, G. Y., Donahue, O. M., & Thomas, T. R. (2004) · Metabolism · doi:10.1016/j.metabol.2004.05.012 · Cited by 36
Metadata
- Authors
- Minihane, A. M., Khan, S., Leigh-Firbank, E. C., Talmud, P., Wright, J. W., Murphy, M. C., Griffin, B. A., & Williams, C. M.
- Affiliations
- University of Surrey (GB)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2000-08
- Volume
- 20
- Issue
- 8
- Pages
- 1990-1997
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2133738729
- Cited by
- 215
- References
- 70
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 8 · 2020: 4 · 2019: 8 · 2018: 6 · 2017: 13 · 2016: 7 · 2015: 5 · 2014: 12 · 2013: 12 · 2012: 12
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- APOE polymorphism, fish oil supplementation, eicosapentaenoic acid, docosahexaenoic acid, atherogenic lipoprotein phenotype, dyslipidemia, postprandial triglyceride response, HDL cholesterol, LDL cholesterol, lipoprotein lipase activity, APOE ε4 carriers, ApoE2 allele, olive oil placebo
- MeSH terms
- Adult, Aged, Apolipoproteins E, Arteriosclerosis, Double-Blind Method, Fasting, Fatty Acids, Nonesterified, Fish Oils, Food, Genotype, Humans, Lipoproteins, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Phenotype, Placebos, Polymorphism, Genetic, Triglycerides, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review